Search

Alana Harris Dent

Examiner (ID: 7014)

Most Active Art Unit
1643
Art Unit(s)
1643, 1642
Total Applications
1512
Issued Applications
526
Pending Applications
351
Abandoned Applications
660

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 10110043 [patent_doc_number] => 09145446 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-29 [patent_title] => 'Conjugate comprising P21 protein for the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 12/608718 [patent_app_country] => US [patent_app_date] => 2009-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 5652 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12608718 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/608718
Conjugate comprising P21 protein for the treatment of cancer Oct 28, 2009 Issued
Array ( [id] => 6575366 [patent_doc_number] => 20100047167 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'COMBINATION THERAPY IN THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 12/605491 [patent_app_country] => US [patent_app_date] => 2009-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9129 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047167.pdf [firstpage_image] =>[orig_patent_app_number] => 12605491 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/605491
COMBINATION THERAPY IN THE TREATMENT OF CANCER Oct 25, 2009 Abandoned
Array ( [id] => 6477499 [patent_doc_number] => 20100041594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'Use of Aplidine for the Treatment of Pancreatic Cancer' [patent_app_type] => utility [patent_app_number] => 12/604900 [patent_app_country] => US [patent_app_date] => 2009-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5040 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041594.pdf [firstpage_image] =>[orig_patent_app_number] => 12604900 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/604900
Use of Aplidine for the Treatment of Pancreatic Cancer Oct 22, 2009 Abandoned
Array ( [id] => 6614726 [patent_doc_number] => 20100063747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'Using Plasma Proteomic Pattern For Diagnosis, Classification, Prediction of Response to Therapy and Clinical Behavior, Stratification of Therapy, and Monitoring Disease in Hematologic Malignancies' [patent_app_type] => utility [patent_app_number] => 12/582998 [patent_app_country] => US [patent_app_date] => 2009-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 14081 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20100063747.pdf [firstpage_image] =>[orig_patent_app_number] => 12582998 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/582998
Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disease in hematologic malignancies Oct 20, 2009 Issued
Array ( [id] => 7499520 [patent_doc_number] => 20110262471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'RAB6KIFL/KIF20A EPITOPE PEPTIDE AND VACCINES CONTAINING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/125548 [patent_app_country] => US [patent_app_date] => 2009-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17412 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20110262471.pdf [firstpage_image] =>[orig_patent_app_number] => 13125548 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/125548
RAB6KIFL/KIF20A epitope peptide and vaccines containing the same Oct 14, 2009 Issued
Array ( [id] => 7744158 [patent_doc_number] => 20120021937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'DETECTION OF CARCINOMA IN SITU IN SEMEN SPECIMENS' [patent_app_type] => utility [patent_app_number] => 13/124405 [patent_app_country] => US [patent_app_date] => 2009-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15133 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20120021937.pdf [firstpage_image] =>[orig_patent_app_number] => 13124405 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/124405
DETECTION OF CARCINOMA IN SITU IN SEMEN SPECIMENS Oct 7, 2009 Abandoned
Array ( [id] => 6323010 [patent_doc_number] => 20100196891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'IBC-1 (Invasive Breast Cancer-1), a Putative Oncogene Amplified in Breast Cancer' [patent_app_type] => utility [patent_app_number] => 12/573017 [patent_app_country] => US [patent_app_date] => 2009-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11998 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20100196891.pdf [firstpage_image] =>[orig_patent_app_number] => 12573017 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/573017
IBC-1 (Invasive Breast Cancer-1), a putative oncogene amplified in breast cancer Oct 1, 2009 Issued
Array ( [id] => 6446956 [patent_doc_number] => 20100105051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF BREAST CANCER' [patent_app_type] => utility [patent_app_number] => 12/567205 [patent_app_country] => US [patent_app_date] => 2009-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47619 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105051.pdf [firstpage_image] =>[orig_patent_app_number] => 12567205 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/567205
COMPOSITIONS, KITS, AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF BREAST CANCER Sep 24, 2009 Abandoned
Array ( [id] => 10505284 [patent_doc_number] => 09233144 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-01-12 [patent_title] => 'Tyrosine kinase receptor TYRO3 as a therapeutic target in the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 13/062804 [patent_app_country] => US [patent_app_date] => 2009-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 24 [patent_no_of_words] => 10145 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13062804 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/062804
Tyrosine kinase receptor TYRO3 as a therapeutic target in the treatment of cancer Sep 17, 2009 Issued
Array ( [id] => 7574141 [patent_doc_number] => 20110269797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'ANLN PROTEIN AS AN ENDOCRINE TREATMENT PREDICTIVE FACTOR' [patent_app_type] => utility [patent_app_number] => 13/061436 [patent_app_country] => US [patent_app_date] => 2009-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 31822 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269797.pdf [firstpage_image] =>[orig_patent_app_number] => 13061436 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/061436
ANLN PROTEIN AS AN ENDOCRINE TREATMENT PREDICTIVE FACTOR Aug 31, 2009 Abandoned
Array ( [id] => 5374242 [patent_doc_number] => 20090311803 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'Treatment Of Tumors Expressing Mutant EGF Receptors' [patent_app_type] => utility [patent_app_number] => 12/544495 [patent_app_country] => US [patent_app_date] => 2009-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13349 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20090311803.pdf [firstpage_image] =>[orig_patent_app_number] => 12544495 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/544495
Treatment Of Tumors Expressing Mutant EGF Receptors Aug 19, 2009 Abandoned
Array ( [id] => 8749276 [patent_doc_number] => 08415107 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-09 [patent_title] => 'Thrombospondin fragments and binding agents in the detection, diagnosis and evaluation of cancer' [patent_app_type] => utility [patent_app_number] => 12/543855 [patent_app_country] => US [patent_app_date] => 2009-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17719 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 219 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12543855 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/543855
Thrombospondin fragments and binding agents in the detection, diagnosis and evaluation of cancer Aug 18, 2009 Issued
Array ( [id] => 5552282 [patent_doc_number] => 20090286268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'Assays for Cancer Patient Monitoring Based on Levels of Analyte Components of the Plasminogen Activator System in Body Fluid Samples' [patent_app_type] => utility [patent_app_number] => 12/507737 [patent_app_country] => US [patent_app_date] => 2009-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 20403 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20090286268.pdf [firstpage_image] =>[orig_patent_app_number] => 12507737 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/507737
Assays for Cancer Patient Monitoring Based on Levels of Analyte Components of the Plasminogen Activator System in Body Fluid Samples Jul 21, 2009 Abandoned
Array ( [id] => 5557774 [patent_doc_number] => 20090269351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'METHOD OF DIAGNOSING AND TREATING GLIOMA' [patent_app_type] => utility [patent_app_number] => 12/498181 [patent_app_country] => US [patent_app_date] => 2009-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 40925 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20090269351.pdf [firstpage_image] =>[orig_patent_app_number] => 12498181 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/498181
METHOD OF DIAGNOSING AND TREATING GLIOMA Jul 5, 2009 Abandoned
Array ( [id] => 9502996 [patent_doc_number] => 08741306 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-03 [patent_title] => 'Kidney specific tumor vaccine directed against kidney tumor antigen G-250' [patent_app_type] => utility [patent_app_number] => 12/479415 [patent_app_country] => US [patent_app_date] => 2009-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 22 [patent_no_of_words] => 22668 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12479415 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/479415
Kidney specific tumor vaccine directed against kidney tumor antigen G-250 Jun 4, 2009 Issued
Array ( [id] => 8265840 [patent_doc_number] => 20120165268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'P53 FUSION PROTEINS AND METHODS OF MAKING AND USING THEREOF' [patent_app_type] => utility [patent_app_number] => 13/321805 [patent_app_country] => US [patent_app_date] => 2009-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14100 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13321805 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/321805
P53 FUSION PROTEINS AND METHODS OF MAKING AND USING THEREOF May 27, 2009 Abandoned
Array ( [id] => 6396267 [patent_doc_number] => 20100304409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'METHOD FOR DETECTING PREMATURE SENESCENCE IN TUMOR CELLS AND A KIT FOR DETECTING PREMATURE SENESCENCE IN TUMOR CELLS' [patent_app_type] => utility [patent_app_number] => 12/472135 [patent_app_country] => US [patent_app_date] => 2009-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11378 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20100304409.pdf [firstpage_image] =>[orig_patent_app_number] => 12472135 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/472135
METHOD FOR DETECTING PREMATURE SENESCENCE IN TUMOR CELLS AND A KIT FOR DETECTING PREMATURE SENESCENCE IN TUMOR CELLS May 25, 2009 Abandoned
Array ( [id] => 5551771 [patent_doc_number] => 20090285757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'METHODS OF TARGETING CELLS FOR DIAGNOSIS AND THERAPY' [patent_app_type] => utility [patent_app_number] => 12/467845 [patent_app_country] => US [patent_app_date] => 2009-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15068 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20090285757.pdf [firstpage_image] =>[orig_patent_app_number] => 12467845 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/467845
METHODS OF TARGETING CELLS FOR DIAGNOSIS AND THERAPY May 17, 2009 Abandoned
Array ( [id] => 5367019 [patent_doc_number] => 20090304578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Cancerous Disease Modifying Antibodies' [patent_app_type] => utility [patent_app_number] => 12/467036 [patent_app_country] => US [patent_app_date] => 2009-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13762 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20090304578.pdf [firstpage_image] =>[orig_patent_app_number] => 12467036 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/467036
Cancerous Disease Modifying Antibodies May 14, 2009 Abandoned
Array ( [id] => 6631635 [patent_doc_number] => 20100035339 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'HUMAN DIACYLGLYCEROL ACYLTRANSFERASE 2 (DGAT2) FAMILY MEMBERS AND USES THEREFOR' [patent_app_type] => utility [patent_app_number] => 12/433304 [patent_app_country] => US [patent_app_date] => 2009-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44925 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20100035339.pdf [firstpage_image] =>[orig_patent_app_number] => 12433304 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/433304
HUMAN DIACYLGLYCEROL ACYLTRANSFERASE 2 (DGAT2) FAMILY MEMBERS AND USES THEREFOR Apr 29, 2009 Abandoned
Menu